BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32323827)

  • 1. MicroRNA‑363‑3p inhibits cell proliferation and induces apoptosis in retinoblastoma cells via the Akt/mTOR signaling pathway by targeting PIK3CA.
    Ma X; Jin L; Lei X; Tong J; Wang R
    Oncol Rep; 2020 May; 43(5):1365-1374. PubMed ID: 32323827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA‑126‑3p suppresses HeLa cell proliferation, migration and invasion, and increases apoptosis via the PI3K/PDK1/AKT pathway.
    Ichikawa R; Kawasaki R; Iwata A; Otani S; Nishio E; Nomura H; Fujii T
    Oncol Rep; 2020 Apr; 43(4):1300-1308. PubMed ID: 32323808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR‑10a increases the cisplatin resistance of lung adenocarcinoma circulating tumor cells via targeting PIK3CA in the PI3K/Akt pathway.
    Huang T; Ren K; Ding G; Yang L; Wen Y; Peng B; Wang G; Wang Z
    Oncol Rep; 2020 Jun; 43(6):1906-1914. PubMed ID: 32186774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA‑93‑5p promotes the progression of human retinoblastoma by regulating the PTEN/PI3K/AKT signaling pathway.
    Cao Y; Xia F; Wang P; Gao M
    Mol Med Rep; 2018 Dec; 18(6):5807-5814. PubMed ID: 30365088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of microRNA‑182 inhibits cell viability, invasion and angiogenesis in retinoblastoma through inhibition of the PI3K/AKT pathway and CADM2 upregulation.
    Huang YX; Nie XG; Li GD; Fan DS; Song LL; Zhang XL
    Int J Oncol; 2018 Dec; 53(6):2615-2626. PubMed ID: 30320366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA‑382 inhibits cell proliferation and invasion of retinoblastoma by targeting BDNF‑mediated PI3K/AKT signalling pathway.
    Song D; Diao J; Yang Y; Chen Y
    Mol Med Rep; 2017 Nov; 16(5):6428-6436. PubMed ID: 28901408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-129-5p suppresses proliferation, migration and invasion of retinoblastoma cells through PI3K/AKT signaling pathway by targeting PAX6.
    Liu Y; Liang G; Wang H; Liu Z
    Pathol Res Pract; 2019 Dec; 215(12):152641. PubMed ID: 31727502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA‑448 inhibits the progression of retinoblastoma by directly targeting ROCK1 and regulating PI3K/AKT signalling pathway.
    Wu S; Ai N; Liu Q; Zhang J
    Oncol Rep; 2018 May; 39(5):2402-2412. PubMed ID: 29517104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA‑936 inhibits the malignant phenotype of retinoblastoma by directly targeting HDAC9 and deactivating the PI3K/AKT pathway.
    Xu L; Li W; Shi Q; Wang M; Li H; Yang X; Zhang J
    Oncol Rep; 2020 Feb; 43(2):635-645. PubMed ID: 31922233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of circular RNA hsa_circ_0001649 indicates poor prognosis for retinoblastoma and regulates cell proliferation and apoptosis via AKT/mTOR signaling pathway.
    Xing L; Zhang L; Feng Y; Cui Z; Ding L
    Biomed Pharmacother; 2018 Sep; 105():326-333. PubMed ID: 29864621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SCARA5 suppresses the proliferation and migration, and promotes the apoptosis of human retinoblastoma cells by inhibiting the PI3K/AKT pathway.
    Wang J; Wang S; Chen L; Tan J
    Mol Med Rep; 2021 Mar; 23(3):. PubMed ID: 33495818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA‑363‑3p inhibits hepatocarcinogenesis by targeting HMGA2 and is associated with liver cancer stage.
    Wang J; Liang H; Ge H; Guo X; Gu D; Yuan Y
    Mol Med Rep; 2019 Feb; 19(2):935-942. PubMed ID: 30535489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA‑153‑3p suppresses retinoblastoma cell growth and invasion via targeting the IGF1R/Raf/MEK and IGF1R/PI3K/AKT signaling pathways.
    Guo L; Bai Y; Ni T; Li Y; Cao R; Ji S; Li S
    Int J Oncol; 2021 Jul; 59(1):. PubMed ID: 34036380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of microRNA‑198 suppresses cell proliferation and invasion in retinoblastoma by directly targeting PTEN.
    Wei D; Miao Y; Yu L; Wang D; Wang Y
    Mol Med Rep; 2018 Jul; 18(1):595-602. PubMed ID: 29749457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-140-5p suppresses retinoblastoma cell growth via inhibiting c-Met/AKT/mTOR pathway.
    Liao Y; Yin X; Deng Y; Peng X
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30291212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-337-3p suppresses proliferation of epithelial ovarian cancer by targeting PIK3CA and PIK3CB.
    Zhang Z; Zhang L; Wang B; Wei R; Wang Y; Wan J; Zhang C; Zhao L; Zhu X; Zhang Y; Chu C; Guo Q; Yin X; Li X
    Cancer Lett; 2020 Jan; 469():54-67. PubMed ID: 31629932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-21 inhibitor suppressed the progression of retinoblastoma via the modulation of PTEN/PI3K/AKT pathway.
    Gui F; Hong Z; You Z; Wu H; Zhang Y
    Cell Biol Int; 2016 Dec; 40(12):1294-1302. PubMed ID: 27600360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR‑142‑5p inhibits pancreatic cancer cell migration and invasion by targeting PIK3CA.
    Zhu J; Zhou L; Wei B; Qian Z; Wang J; Hui H; Sun Y
    Mol Med Rep; 2020 Sep; 22(3):2085-2092. PubMed ID: 32705244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of Biglycan is Associated with Resistance to Rapamycin in Human WERI-Rb-1 Retinoblastoma Cells by Inducing the Activation of the Phosphatidylinositol 3-Kinases (PI3K)/Akt/Nuclear Factor kappa B (NF-κB) Signaling Pathway.
    Fang D; Lai Z; Wang Y
    Med Sci Monit; 2019 Sep; 25():6639-6648. PubMed ID: 31483776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumol inhibits the malignant progression of prostate cancer and regulates the PDK1/AKT/mTOR pathway by targeting miR‑9.
    Sheng W; Xu W; Ding J; Li L; You X; Wu Y; He Q
    Oncol Rep; 2021 Nov; 46(5):. PubMed ID: 34590156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.